Amag Pharmaceuticals

Novobiotic Pharmaceuticals is a biotechnology company located in Cambridge, Massachusetts, specializing in the development of innovative pharmaceutical solutions. The company focuses on harnessing the potential of natural products, particularly from microbial sources, to address unmet medical needs. With a dedicated team of scientists and researchers, Novobiotic Pharmaceuticals is committed to advancing the field of drug discovery and development. Their work emphasizes the importance of scientific research in creating effective therapies for various health challenges. Generated from the website

Takeda Pharmaceuticals USA, based in Cambridge, MA, is a global pharmaceutical company dedicated to creating better health for people and a brighter future for the world. With a focus on research and development, Takeda strives to transform lives through innovative medicines in areas such as gastrointestinal and inflammation, rare diseases, oncology, neuroscience, plasma-derived therapies, and vaccines. Committed to sustainability and corporate responsibility, Takeda emphasizes access to medicines, ethical practices, and transparency in governance. Through collaboration with diverse colleagues and a patient-centered approach, Takeda continues to advance science and technology to improve healthcare outcomes worldwide. Generated from the website

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.